The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

A Breakthrough in Cancer Prevention for IBD Patients?

For millions of Americans living with inflammatory bowel disease (IBD)—including ulcerative colitis and Crohn’s disease—the risk of colorectal cancer is a constant worry.

Many are stuck in a cycle of frequent colonoscopies (sometimes every one to three years) and invasive biopsies, all in an effort to catch pre-cancerous changes before they become deadly.

But what if there was a better way?

A new test—developed by researchers at The Institute of Cancer Research in London—could accurately predict colorectal cancer risk in IBD patients with over 90% accuracy.

So, is this the future of cancer prevention—or is there more to the story?

This test could mean:

  • Fewer unnecessary colonoscopies
  • Avoiding risky surgeries
  • A better way to target high-risk patients before cancer develops

Researchers discovered that pre-cancerous cells in IBD patients show specific DNA changes—losing or gaining multiple copies of genetic material.

Using this discovery, they developed an algorithm that analyzes a small biopsy sample to determine whether someone is at high or low risk for developing colorectal cancer within five years.

If validated in real-world clinical trials, this test could replace frequent, invasive screenings with a simple genetic test on a routine biopsy.

It could revolutionize cancer prevention—but there’s one big question.

Why is Big Pharma watching closely?

We’ve seen it before: A breakthrough discovery in disease prevention comes along…
And suddenly, Big Pharma presses pause.

Could this test be too effective?

Remember, Big Pharma makes billions off of colonoscopies, biopsies, and cancer treatments—so anything that reduces their bottom line is bound to face resistance.

Will they try to delay approval to push more expensive procedures instead? Or will they hijack the research, repackage it, and monetize it on their terms?

History has shown that when it comes to real breakthroughs, Big Pharma isn’t always on the side of patients—they’re on the side of profits.

So what can you do in the meantime?

This test is a huge step forward, but you don’t have to wait for approval to take action now.

Feed Your Gut the Right Way

A healthy gut microbiome is your first line of defense against cancer:

  • Cruciferous vegetables (broccoli, cauliflower, kale) contain sulforaphane, which fights inflammation and abnormal cell growth.
  • Apples and berries are rich in polyphenols, compounds that protect against colon cancer.
  • Fiber from whole grains and legumes helps flush toxins from the digestive system.

Reduce Chronic Inflammation

Inflammation is a major driver of colorectal cancer in IBD patients. Keep it in check with:

  • Curcumin (turmeric extract) – Powerful anti-inflammatory properties, especially for gut health.
  • Omega-3 fatty acids – Found in wild-caught fish, walnuts, and flaxseeds, omega-3s fight inflammation.
  • Green tea extract – Contains EGCG, a compound linked to lower colon cancer risk.

Avoid Cancer-Triggering Foods

Certain foods fuel inflammation and abnormal cell growth:

  • Ultra-processed foods – Linked to higher rates of colon cancer.
  • Red & processed meats – High in carcinogens and gut-irritating compounds.
  • Refined sugar & artificial sweeteners – Can disrupt the gut microbiome.

Get Screened—But Be Smart About It

  • Talk to your doctor about your personal risk level—especially if you have IBD.
  • Ask about the new test and whether it’s available in clinical trials.
  • Stay proactive with screenings—but don’t agree to invasive procedures unless truly necessary.

This new test could change the game for IBD patients—reducing unnecessary procedures while catching cancer earlier.

But as we’ve seen before, Big Pharma doesn’t always embrace change when it threatens their profit machine.

That’s why you have to take control of your own health.

  • Support your gut with the right foods and supplements.
  • Stay informed about the latest screening options.
  • Advocate for the most effective, least invasive care possible.

And if you’re looking for even more ways to protect yourself naturally, check out HSI’s “Beyond Chemotherapy” Cancer Protocol—which includes powerful research-backed strategies to reduce cancer risk without Big Pharma’s overpriced interventions.

Because when it comes to your health, you deserve the truth—not just the industry’s latest sales pitch.

To knowing all of your options,

Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team

Sources:

Pelc, C. (2025, February 4). New test may predict which IBD patients have higher colorectal cancer risk. Medicalnewstoday.com; Medical News Today. https://www.medicalnewstoday.com/articles/new-test-predict-ibd-patients-higher-colorectal-cancer-risk#Determining-who-is-at-higher-risk

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or [email protected]. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at [email protected] or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at [email protected].

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at [email protected].